JP2000505434A - 生体応答性、薬理学的活性重合体及びこれから製造された物品 - Google Patents
生体応答性、薬理学的活性重合体及びこれから製造された物品Info
- Publication number
- JP2000505434A JP2000505434A JP9528842A JP52884297A JP2000505434A JP 2000505434 A JP2000505434 A JP 2000505434A JP 9528842 A JP9528842 A JP 9528842A JP 52884297 A JP52884297 A JP 52884297A JP 2000505434 A JP2000505434 A JP 2000505434A
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- pharmacologically active
- substance according
- polymer substance
- antimicrobial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/595—Polyamides, e.g. nylon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/48—Polyethers
- C08G18/50—Polyethers having heteroatoms other than oxygen
- C08G18/5021—Polyethers having heteroatoms other than oxygen having nitrogen
- C08G18/5024—Polyethers having heteroatoms other than oxygen having nitrogen containing primary and/or secondary amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.薬理学的活性フラグメントを含有する主鎖を有する生体応答性、薬理学的 活性高分子物質であって、上記薬理学的活性フラグメントが上記主鎖の内部で少 なくとも2個の官能基により該主鎖に共有結合されている生体応答性、薬理学的 活性高分子物質。 2.前記フラグメントは2個の官能基により主鎖に共有結合している、請求項 1に記載の高分子物質。 3.前記主鎖は1個又はそれ以上のポリアミド、ポリ尿素、ポリウレタン又は ポリスルホンアミド結合を含有する、請求項1又は2に記載の高分子物質。 4.1個又はそれ以上のポリビニル、ポリエステル、ポリカーボネート又はポ リエーテル結合を更に含有する、請求項3に記載の高分子物質。 5.前記ポリアミド、ポリ尿素、ポリウレタン又はポリスルホンアミド結合は 2個又はそれ以上のイソシアネート官能基から形成される、請求項3に記載の高 分子物質。 6.前記ポリエステルはポリカプロラクトンジオールから形成される、請求項 4に記載の高分子物質。 7.前記ポリエーテルはポリエーテルジアミンから形成される、請求項4に記 載の高分子物質。 8.前記主鎖は1,6-ジアミドヘキサン又は1,12-ジアミドドデカンポリウレタ ン、ポリ尿素、ポリアミド又はポリスルホンアミド結合を含有する、請求項1〜 7のいずれかに記載の高分子物質。 9.前記フラグメントは、生体内の生化学的作用の下で抗炎症、抗菌、抗微生 物又は防かび活性を提供する、請求項1〜8のいずれかに記載の高分子物質。 10.前記フラグメントは抗菌性フルオロキノロンから形成される、請求項9に 記載の高分子物質。 11.前記抗菌剤はシプロフロキサシン(1-シクロプロピル-6-フルオロ-1,4 -ジヒドロ-4-オキソ-7-ピペラジンキノロン-3-カルボン酸)である、請求項10に 記載の高分子物質。 12.ポリイソシアネートと、オリゴマー状α-ωジオールと、ジアミン又はア ミノアルコールと、共有結合し得る薬理学的活性化合物との反応により製造され る、請求項1に記載の高分子物質。 13.前記ポリイソシアネートはヘキサメチレンジイソシアネート及びドデシル ジイソシアネートから選ばれ;前記オリゴマー状ジオールはポリカプロラクトン ジオールであり;薬理学的活性化合物は抗菌性フルオロキノロンである、請求項 1に記載の高分子物質。 14.(a)前記ヘキサメチレンジイソシアネート又はドデシルジイソシアネート とポリカプロラクトンジオールとを反応させてプレポリマーを形成させ;ついで (b)上記プレポリマーとシプロフロキサシンとを反応させることにより製造され る、請求項13に記載の高分子物質。 15.2,000〜200,000から選ばれたポリスチレン当量分子量を有する、請求項1 に記載の高分子物質。 16.全部又は一部が、請求項1に記載の生体応答性、薬理学的活性高分子物質 からなる固体基材。 17.全部又は一部が、請求項1に記載の生体応答性、薬理学的活性高分子物質 で被覆されている固体基材。 18.アクセス装置、縫合材、フィルム、パッチ又は歯科用繊維である、請求項 16又は17に記載の基材。 19.請求項1〜15のいずれかに記載の高分子物質又は請求項16〜18のいずれか に記載の基材を哺乳動物の選択された部位又はこれに隣接する位置に設置又は配 置することからなる、哺乳動物の選択された部位への生体応答性、薬理学的活性 化合物の供給方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1169996P | 1996-02-15 | 1996-02-15 | |
US60/011,699 | 1996-02-15 | ||
US1439196P | 1996-03-28 | 1996-03-28 | |
US60/014,391 | 1996-03-28 | ||
PCT/CA1997/000089 WO1997029778A2 (en) | 1996-02-15 | 1997-02-10 | Bioresponsive pharmacologically-active polymers and articles made therefrom |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000505434A true JP2000505434A (ja) | 2000-05-09 |
JP4341986B2 JP4341986B2 (ja) | 2009-10-14 |
Family
ID=26682693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52884297A Expired - Fee Related JP4341986B2 (ja) | 1996-02-15 | 1997-02-10 | 生体応答性、薬理学的活性重合体及びこれから製造された物品 |
Country Status (7)
Country | Link |
---|---|
US (1) | US5798115A (ja) |
EP (1) | EP0874643B1 (ja) |
JP (1) | JP4341986B2 (ja) |
AU (1) | AU705101B2 (ja) |
CA (1) | CA2243649C (ja) |
DE (1) | DE69708461T2 (ja) |
WO (1) | WO1997029778A2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008133359A (ja) * | 2006-11-28 | 2008-06-12 | Headway Advanced Materials Inc | 分散性があり長期効果タイプの防カビ機能を有するポリイソシアネート及びそのカビ防止材料 |
JP2009528431A (ja) * | 2006-02-28 | 2009-08-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 抗菌剤放出ポリマー |
JP2011516503A (ja) * | 2008-04-07 | 2011-05-26 | インターフェース バイオロジクス,インコーポレーテッド | 細菌感染症を治療するための併用療法 |
JP2020509106A (ja) * | 2017-02-07 | 2020-03-26 | ゴールデン レデイ カンパニー ソチエタ ペル アチオーニ | 抗菌性を有する繊維物品の製造のための変性ポリアミドの使用 |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19638570A1 (de) * | 1996-09-20 | 1998-03-26 | Bayer Ag | Wirkstoffhaltige thermoplastische Polyurethane |
US6468519B1 (en) * | 1997-09-10 | 2002-10-22 | Rutgers, The State University Of New Jersey | Polyanhydrides with biologically active degradation products |
US7122615B1 (en) | 1998-09-10 | 2006-10-17 | Rutgers, The State University Of New Jersey | Polyanhydrides with therapeutically useful degradation products |
US6486214B1 (en) * | 1997-09-10 | 2002-11-26 | Rutgers, The State University Of New Jersey | Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
WO2000007633A1 (de) * | 1998-08-07 | 2000-02-17 | Leica Microsystems Ag | Medizinisches gerät |
US6366794B1 (en) * | 1998-11-20 | 2002-04-02 | The University Of Connecticut | Generic integrated implantable potentiostat telemetry unit for electrochemical sensors |
US20030099682A1 (en) * | 1998-11-20 | 2003-05-29 | Francis Moussy | Apparatus and method for control of tissue/implant interactions |
US6585767B1 (en) * | 1998-11-23 | 2003-07-01 | Agion Technologies, Inc. | Antimicrobial suturing ring for heart valve |
US6787302B2 (en) * | 1999-10-25 | 2004-09-07 | Genprime, Inc. | Method and apparatus for prokaryotic and eukaryotic cell quantitation |
US6673568B1 (en) * | 1999-10-25 | 2004-01-06 | Genprime, Inc. | Method and apparatus for prokaryotic and eukaryotic cell quantitation |
US20040038948A1 (en) | 1999-12-07 | 2004-02-26 | Uhrich Kathryn E. | Therapeutic compositions and methods |
US7179849B2 (en) * | 1999-12-15 | 2007-02-20 | C. R. Bard, Inc. | Antimicrobial compositions containing colloids of oligodynamic metals |
US6579539B2 (en) | 1999-12-22 | 2003-06-17 | C. R. Bard, Inc. | Dual mode antimicrobial compositions |
US20010049422A1 (en) * | 2000-04-14 | 2001-12-06 | Phaneuf Matthew D. | Methods of applying antibiotic compounds to polyurethane biomaterials using textile dyeing technology |
WO2002055614A2 (en) * | 2001-01-12 | 2002-07-18 | Dsm Ip Assets B.V. | Radiation-curable composition and products coated therewith |
CA2349989A1 (en) * | 2001-06-07 | 2002-12-07 | Paul J. Santerre | Bioactive surface modifiers for polymers and articles made therefrom |
US20050129732A1 (en) * | 2001-07-13 | 2005-06-16 | Flow Focusing, Inc. | Biodegradable, antibiotic, controlled release tape |
DE10146814A1 (de) * | 2001-09-18 | 2003-04-03 | Uronova Gmbh | Medizinisches Nahtmaterial |
MXPA04005332A (es) | 2001-12-03 | 2005-05-16 | Bard Inc C R | Dispositivo medico resistente a microbios, revestimiento polimerico resistente a microbios y metodos para producir los mismos. |
US20030216758A1 (en) * | 2001-12-28 | 2003-11-20 | Angiotech Pharmaceuticals, Inc. | Coated surgical patches |
US20030166823A1 (en) * | 2002-03-01 | 2003-09-04 | Thomas Daly | Polymers with antimicrobial, bioresistant and fungal resistant properties |
US7037527B2 (en) * | 2002-01-25 | 2006-05-02 | University Of Rhode Island | Bifunctionalized polyester material for surface treatment and biomodification |
US20030162273A1 (en) * | 2002-02-04 | 2003-08-28 | Anastasios Melis | Modulation of sulfate permease for photosynthetic hydrogen production |
US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
DE60328486D1 (de) * | 2002-05-24 | 2009-09-03 | Angiotech Int Ag | Zusammensetzungen und verfahren zur beschichtung medizinischer implantate |
US20040002552A1 (en) * | 2002-06-26 | 2004-01-01 | Thomas Daly | Esters with antimicrobial, bioresistant and fungal resistant properties |
US20090137838A1 (en) * | 2006-05-24 | 2009-05-28 | Thomas Daly | Esters with antimicrobial, bioresistant and fungal resistant properties |
US7439376B2 (en) * | 2002-06-26 | 2008-10-21 | Tpat Ip Llc | Esters with antimicrobial, bioresistant and fungal resistant properties |
WO2004006863A2 (en) * | 2002-07-17 | 2004-01-22 | Rutgers, The State University | Therapeutic devices for patterned cell growth |
US7488757B2 (en) | 2003-03-24 | 2009-02-10 | Becton, Dickinson And Company | Invisible antimicrobial glove and hand antiseptic |
JP2006525445A (ja) * | 2003-04-23 | 2006-11-09 | ザ ユニバーシティ オブ アクロン | 封鎖反応性材料本特許出願は、2003年4月23日に出願された米国仮特許出願第60/464,879号に基づく優先権を主張する。 |
US20040215335A1 (en) * | 2003-04-25 | 2004-10-28 | Brin David S. | Methods and apparatus for treatment of aneurysmal tissue |
DE10352575B3 (de) * | 2003-11-11 | 2005-05-04 | Leica Microsystems Nussloch Gmbh | Kryostat mit einem Innenbehälter zur Aufnahme eines Mikrotoms |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
AU2005244037A1 (en) * | 2004-05-14 | 2005-11-24 | Interface Biologics Inc. | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
US8246569B1 (en) | 2004-08-17 | 2012-08-21 | California Institute Of Technology | Implantable intraocular pressure drain |
CA2586927A1 (en) * | 2004-11-09 | 2006-05-18 | Angiotech Biocoatings Corp. | Antimicrobial needle coating for extended infusion |
US20060099332A1 (en) * | 2004-11-10 | 2006-05-11 | Mats Eriksson | Process for producing a repair coating on a coated metallic surface |
US7794742B2 (en) * | 2005-02-08 | 2010-09-14 | University Of Washington | Devices for promoting epithelial cell differentiation and keratinization |
AU2005100176A4 (en) * | 2005-03-01 | 2005-04-07 | Gym Tv Pty Ltd | Garbage bin clip |
US7517914B2 (en) * | 2005-04-04 | 2009-04-14 | Boston Scientificscimed, Inc. | Controlled degradation materials for therapeutic agent delivery |
US20060258994A1 (en) * | 2005-05-12 | 2006-11-16 | Avery Robert L | Implantable delivery device for administering pharmacological agents to an internal portion of a body |
ATE497797T1 (de) * | 2006-03-14 | 2011-02-15 | Univ Southern California | Mems-vorrichtung zur wirkstofffreisetzung |
DE102006033312A1 (de) * | 2006-07-17 | 2008-01-31 | Heraeus Kulzer Gmbh | Dentales Implantatsystemteil mit einer Beschichtung |
EP2102144A4 (en) | 2006-09-13 | 2011-03-23 | Univ Rutgers | ACTIVE SUBSTANCES AND THEIR OLIGOMERS AND POLYMERS |
AT505312A1 (de) * | 2007-05-15 | 2008-12-15 | Recticel Schlafkomfort Gmbh Sc | Polyurethan-werkstoff mit einer bioziden ausrüstung |
US9308124B2 (en) * | 2007-12-20 | 2016-04-12 | University Of Southern California | Apparatus and methods for delivering therapeutic agents |
WO2009089094A2 (en) | 2008-01-03 | 2009-07-16 | University Of Southern California | Implantable drug-delivery devices, and apparatus and methods for refilling the devices |
EP2323716B1 (en) * | 2008-05-08 | 2015-03-04 | MiniPumps, LLC | Drug-delivery pumps |
US9849238B2 (en) | 2008-05-08 | 2017-12-26 | Minipumps, Llc | Drug-delivery pump with intelligent control |
CN102202719B (zh) * | 2008-05-08 | 2014-11-26 | 迷你泵有限责任公司 | 可植入泵和用于可植入泵的插管 |
CA2723723C (en) | 2008-05-08 | 2019-06-25 | Replenish Pumps, Llc | Implantable drug-delivery devices, and apparatus and methods for filling the devices |
PT2355853T (pt) * | 2008-10-10 | 2017-03-15 | Polyactiva Pty Ltd | Conjugados polímero biodegradável ¿ unidade bioativa |
EP2340271B1 (en) * | 2008-10-10 | 2018-12-05 | PolyActiva Pty Ltd. | Polymer-bioactive agent conjugates |
US8535655B2 (en) | 2008-10-10 | 2013-09-17 | Polyactiva Pty Ltd. | Biodegradable polymer—bioactive moiety conjugates |
WO2011022484A1 (en) | 2009-08-18 | 2011-02-24 | Replenish Pumps. Llc | Electrolytic drug-delivery pump with adaptive control |
US8741317B2 (en) | 2010-08-19 | 2014-06-03 | Rutgers, The State University Of New Jersey | Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery |
US20140023692A1 (en) * | 2010-11-26 | 2014-01-23 | Lisa Claire Du Toit | Drug delivery device |
US9603997B2 (en) | 2011-03-14 | 2017-03-28 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US10286146B2 (en) | 2011-03-14 | 2019-05-14 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US9919099B2 (en) | 2011-03-14 | 2018-03-20 | Minipumps, Llc | Implantable drug pumps and refill devices therefor |
US9144579B2 (en) | 2012-08-17 | 2015-09-29 | Rutgers, The State University Of New Jersey | Polyesters and methods of use thereof |
US20140120057A1 (en) | 2012-10-25 | 2014-05-01 | Rutgers, The State University Of New Jersey | Polymers and methods thereof for wound healing |
US9387250B2 (en) | 2013-03-15 | 2016-07-12 | Rutgers, The State University Of New Jersey | Therapeutic compositions for bone repair |
US9862672B2 (en) | 2013-05-29 | 2018-01-09 | Rutgers, The State University Of New Jersey | Antioxidant-based poly(anhydride-esters) |
US10023521B2 (en) | 2014-06-13 | 2018-07-17 | Rutgers, The State University Of New Jersey | Process and intermediates for preparing poly(anhydride-esters) |
JP6930918B6 (ja) | 2015-04-10 | 2021-12-15 | ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー | コウジ酸ポリマー |
KR20200121816A (ko) | 2018-02-02 | 2020-10-26 | 리플 테라퓨틱스 코포레이션 | 스테로이드 이량체를 포함하는 유리 제제 및 이의 용도 |
CN109354662B (zh) * | 2018-11-02 | 2021-11-02 | 湖南博隽生物医药有限公司 | 一种防感染内置式血液透析管用材料及其制备方法 |
JP2022548464A (ja) * | 2019-07-10 | 2022-11-21 | リップル セラピューティクス コーポレーションズ | 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用 |
EP4146664A2 (en) | 2020-05-01 | 2023-03-15 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
US5474765A (en) * | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5449720A (en) * | 1993-05-24 | 1995-09-12 | Biotech Australia Pty Limited | Amplification of the VB12 uptake system using polymers |
US5609867A (en) * | 1994-11-01 | 1997-03-11 | American Cyanamid Company | Polymeric antitumor agents |
-
1997
- 1997-02-10 DE DE69708461T patent/DE69708461T2/de not_active Expired - Lifetime
- 1997-02-10 CA CA002243649A patent/CA2243649C/en not_active Expired - Fee Related
- 1997-02-10 AU AU15389/97A patent/AU705101B2/en not_active Ceased
- 1997-02-10 EP EP97901504A patent/EP0874643B1/en not_active Expired - Lifetime
- 1997-02-10 WO PCT/CA1997/000089 patent/WO1997029778A2/en active IP Right Grant
- 1997-02-10 JP JP52884297A patent/JP4341986B2/ja not_active Expired - Fee Related
- 1997-02-13 US US08/799,938 patent/US5798115A/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009528431A (ja) * | 2006-02-28 | 2009-08-06 | タイコ ヘルスケア グループ リミテッド パートナーシップ | 抗菌剤放出ポリマー |
JP2008133359A (ja) * | 2006-11-28 | 2008-06-12 | Headway Advanced Materials Inc | 分散性があり長期効果タイプの防カビ機能を有するポリイソシアネート及びそのカビ防止材料 |
JP2011516503A (ja) * | 2008-04-07 | 2011-05-26 | インターフェース バイオロジクス,インコーポレーテッド | 細菌感染症を治療するための併用療法 |
JP2020509106A (ja) * | 2017-02-07 | 2020-03-26 | ゴールデン レデイ カンパニー ソチエタ ペル アチオーニ | 抗菌性を有する繊維物品の製造のための変性ポリアミドの使用 |
JP2021130818A (ja) * | 2017-02-07 | 2021-09-09 | ゴールデン レデイ カンパニー ソチエタ ペル アチオーニ | 抗菌性を有する繊維物品の製造のための変性ポリアミドの使用 |
JP2022180353A (ja) * | 2017-02-07 | 2022-12-06 | ゴールデン レデイ カンパニー ソチエタ ペル アチオーニ | 抗菌性を有する繊維物品の製造のための変性ポリアミドの使用 |
Also Published As
Publication number | Publication date |
---|---|
CA2243649C (en) | 2009-08-04 |
WO1997029778A2 (en) | 1997-08-21 |
AU705101B2 (en) | 1999-05-13 |
EP0874643B1 (en) | 2001-11-21 |
DE69708461T2 (de) | 2002-06-27 |
EP0874643A2 (en) | 1998-11-04 |
DE69708461D1 (de) | 2002-01-03 |
US5798115A (en) | 1998-08-25 |
AU1538997A (en) | 1997-09-02 |
CA2243649A1 (en) | 1997-08-21 |
JP4341986B2 (ja) | 2009-10-14 |
WO1997029778A3 (en) | 1997-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4341986B2 (ja) | 生体応答性、薬理学的活性重合体及びこれから製造された物品 | |
US8454566B2 (en) | Methods and compositions for the inhibition of biofilms on medical devices | |
EP1343547B1 (en) | Antimicrobial medical devices | |
CA2704962C (en) | Antimicrobial coatings for medical devices containing a polypeptide that generates hydrogen peroxide upon exposure to a ligand and methods for making and using them | |
US6843784B2 (en) | Triclosan and silver compound containing medical devices | |
US8906364B2 (en) | Antimicrobial compositions and uses thereof | |
AU2002231069A1 (en) | Antimicrobial medical devices | |
US10941252B2 (en) | Silicone copolymers, methods of making, and articles | |
US10864296B2 (en) | Polypeptide and hyaluronic acid coatings | |
JP5247144B2 (ja) | 高分子カップリング剤およびそれらから製造された薬学的に活性のあるポリマー | |
CN112843342A (zh) | 具有生物抗污功能的材料、其制备方法及应用 | |
KR100748038B1 (ko) | 생리활성물질 고정화 인공혈관 | |
US11185616B2 (en) | Implantable medical products, a process for the preparation thereof, and use thereof | |
AU2007231679B2 (en) | Antimicrobial medical devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031225 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080430 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080616 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080529 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080707 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080630 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080804 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080729 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080930 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081225 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090209 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090330 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090609 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090707 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120717 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130717 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |